Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
Times cited: 28
- Human herpesvirus-8-transformed endothelial cells have functionally activated vascular endothelial growth factor/vascular endothelial growth factor receptor. American Journal of Pathology. 2002 Academic Article GET IT
- Increased radiosensitivity of normal tissue fibroblasts in patients with acquired immunodeficiency syndrome (AIDS) and with kaposi's sarcoma. International journal of radiation biology. 1995 Academic Article GET IT
- Primary central nervous system lymphoma in AIDS. Results of radiation therapy. Cancer. 1989 Academic Article GET IT
- Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results. Annals of internal medicine. 1986 Academic Article GET IT